Contact Us
Aminoglycosides Global Market Report 2025
Global Aminoglycosides Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Aminoglycosides Global Market Report 2025

By Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products), By Route Of Administration (Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral), By Application (Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Aminoglycosides Market Overview

• Aminoglycosides market size has reached to $1.84 billion in 2024

• Expected to grow to $2.4 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%

• Growth Driver: Aminoglycosides Market Surges Amidst Escalating Animal Disease Outbreaks

• Market Trend: Process Innovation Emerges As A Pivotal Trend In The Aminoglycosides Market

Asia-Pacific was the largest region in 2024 and North America is the fastest growing region.

What Is Covered Under Aminoglycosides Market?

Aminoglycoside is a class of antibiotics that inhibits protein synthesis. These are used in the treatment of aerobic gram-negative bacilli infections of the abdomen and urinary tract, as well as bacteremia and endocarditis

The main products of aminoglycosides are neomycin, tobramycin, gentamicin, amikacin, paromomycin, streptomycin, kanamycin and others. The neomycin are used to prevent bacterial infection in the intestines. Neomycin is a broad-spectrum aminoglycoside antibiotic drug that is derived from the metabolic products of Streptomyces fradiae. The route of administration of aminiglycosides includes injectables (parenteral), feed, intra-mammary, topical and oral and applied in veterinary, skin infection, respiratory diseases, UTI & pelvic diseases and other diseases.

Aminoglycosides Market Size and growth rate 2025 to 2029: Graph

What Is The Aminoglycosides Market Size 2025 And Growth Rate?

The aminoglycosides market size has grown steadily in recent years. It will grow from $1.84 billion in 2024 to $1.91 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to antibiotic discovery and development, advancements in medicinal chemistry, clinical effectiveness in treating gram-negative infections, broad-spectrum antibacterial activity, hospital-acquired infection control, global population growth, post-surgery infection prevention, research and development investments.

What Is The Aminoglycosides Market Growth Forecast?

The aminoglycosides market size is expected to see strong growth in the next few years. It will grow to $2.4 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to advancements in antibiotic stewardship, personalized medicine approaches, innovations in drug delivery, global spread of antibiotic-resistant strains, increasing focus on rare diseases, expanding applications in dermatology, patient education on antibiotic use. Major trends in the forecast period include biotechnological innovations, combination therapies, technological advancements in production, price competition.

The forecast of 5.9% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. infectious disease treatment by inflating prices of antibiotics like gentamicin and tobramycin produced in China and Italy, resulting in delayed serious infection management and higher antimicrobial therapy expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Aminoglycosides Market Segmented?

1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products

2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral

3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases

Subsegments:

1) By Neomycin: Topical Formulations, Oral Formulations

2) By Tobramycin: Inhalation Solutions, Injectable Formulations, Ophthalmic Solutions

3) By Gentamicin: Injectable Formulations, Topical Formulations, Ophthalmic Solutions

4) By Amikacin: Injectable Formulations, Inhalation Solutions

5) By Paromomycin: Oral Formulations, Injectable Formulations

6) By Streptomycin: Injectable Formulations, Combination Therapies

7) By Kanamycin: Injectable Formulations, Oral Formulations

8) By Other Products: Combinations Of Aminoglycosides, Novel Aminoglycoside Derivatives

What Is Driving The Aminoglycosides Market? Aminoglycosides Market Surges Amidst Escalating Animal Disease Outbreaks

The rising incidences of animal disease outbreak is a major driver expected to propel the growth of the aminoglycosides market going forward. Animal disease is an impairment of the normal state of an animal that interrupts or modifies its vital functions. Aminoglycosides such as amikacin and gentamicin are the most commonly used in veterinary medicine. For instance, in July 2022, an anthrax outbreak, a disease of humans and other mammals is reported and monitored in the remote areas of the largest national park in Canada– Wood Buffalo National Park. Therefore, the rising incidences of animal disease outbreaks will continue to drive the aminoglycosides industry.

What Is Driving The Aminoglycosides Market? Pet Ownership Surge Fuels Aminoglycosides Market Expansion

The increase in pet ownership is expected to propel the growth of the aminoglycosides market going forward. Pet ownership refers to the act of keeping and caring for animals, commonly referred to as pets, within one's home or living space. Increased pet ownership enhances the Aminoglycoside market by creating a larger customer base, fostering a culture of preventive healthcare for pets, and encouraging investments in veterinary pharmaceuticals to address the diverse health needs of companion animals. For instance, in March 2023, according to Improve International, a US-based veterinary educational resource, there are 38 million pets in 16.2 million UK households, or around 57% of all households. Therefore, the increase in pet ownership is driving the growth of the aminoglycosides industry.

Who Are The Major Players In The Global Aminoglycosides Market?

Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Allergan PLC, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Bristol Myers Squibb Company, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc

What Are The Key Trends Of The Global Aminoglycosides Market? Process Innovation Emerges As A Pivotal Trend In The Aminoglycosides Market

Process innovation is a key trend in the aminoglycosides market. Major companies operating in the aminoglycosides market are focused on developing new process solutions to strengthen their position in the market. For instance, in February 2024, Cipla Limited, an India-based pharmaceutical company, received approval from the Central Drugs Standard Control Organization (CDSCO) for ZEMDRI (plazomicin), an intravenous aminoglycoside antibiotic, in India. This antibiotic is specifically indicated for the treatment of complicated urinary tract infections (cUTIs), including pyelonephritis.

What Are The Key Trends Of The Global Aminoglycosides Market? Innovative Developments In The Aminoglycosides Market For Targeted Bacterial Infections

Major companies operating in the aminoglycosides market are focusing on developing innovative products, such as active ingredients effective against specific bacterial pathogens. An active ingredient is the chemical component in a product, such as a drug or pesticide, that produces the intended therapeutic or biological effect. For instance, in July 2023, Bimeda US, a US-based animal health company, launched SpectoGard, designed to treat various bacterial infections in cattle. A newly injectable solution is available for veterinarians and cattle producers in the U.S. It contains spectinomycin sulfate, an antibiotic used to treat bovine respiratory disease (BRD) caused by specific bacterial pathogens. This solution provides a convenient treatment option to improve herd health. Its FDA status highlights its safety and efficacy in livestock use.

Need data on a specific region in this market?

Aminoglycosides Market Merger And Acquisition: Animal Dermatology Group Expands with Acquisition of Austin Veterinary Dermatology & Allergy

In April 2022, Animal Dermatology Group Inc., a US-based veterinary company acquired Austin Veterinary Dermatology & Allergy for an undisclosed amount. Through this acquisition, Animal Dermatology Group will be able to expand its geographic reach and solidify its position in the market, giving it the ability to offer top-notch treatment for skin diseases in more areas. The purchase is a component of Animal Dermatology Group's continuous endeavors to expand and improve its veterinary dermatology skills. Austin Veterinary Dermatology & Allergy, is a US-based biotechnology company.

Regional Outlook For The Global Aminoglycosides Market

Asia-Pacific was the largest region in the aminoglycosides market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Aminoglycosides Market?

The aminoglycosides market consists of sales of plazomicin and netilmicin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Aminoglycosides Industry?

The aminoglycosides market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the aminoglycosides industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Aminoglycosides Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.91 billion
Revenue Forecast In 2034 $2.4 billion
Growth Rate CAGR of 5.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products
2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral
3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases Subsegments: 1) By Neomycin: Topical Formulations, Oral Formulations
2) By Tobramycin: Inhalation Solutions, Injectable Formulations, Ophthalmic Solutions
3) By Gentamicin: Injectable Formulations, Topical Formulations, Ophthalmic Solutions
4) By Amikacin: Injectable Formulations, Inhalation Solutions
5) By Paromomycin: Oral Formulations, Injectable Formulations 6) By Streptomycin: Injectable Formulations, Combination Therapies 7) By Kanamycin: Injectable Formulations, Oral Formulations 8) By Other Products: Combinations Of Aminoglycosides, Novel Aminoglycoside Derivatives
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Allergan PLC, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Bristol Myers Squibb Company, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Aminoglycosides Market Characteristics

3. Aminoglycosides Market Trends And Strategies

4. Aminoglycosides Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Aminoglycosides Growth Analysis And Strategic Analysis Framework

5.1. Global Aminoglycosides PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Aminoglycosides Market Growth Rate Analysis

5.4. Global Aminoglycosides Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Aminoglycosides Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Aminoglycosides Total Addressable Market (TAM)

6. Aminoglycosides Market Segmentation

6.1. Global Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Neomycin

Tobramycin

Gentamicin

Amikacin

Paromomycin

Streptomycin

Kanamycin

Other Products

6.2. Global Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectables (Parenteral)

Feed

Intra-Mammary

Topical

Oral

6.3. Global Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Veterinary

Skin Infection

Respiratory Diseases

UTI And Pelvic Diseases

Other Diseases

6.4. Global Aminoglycosides Market, Sub-Segmentation Of Neomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Topical Formulations

Oral Formulations

6.5. Global Aminoglycosides Market, Sub-Segmentation Of Tobramycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Inhalation Solutions

Injectable Formulations

Ophthalmic Solutions

6.6. Global Aminoglycosides Market, Sub-Segmentation Of Gentamicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Formulations

Topical Formulations

Ophthalmic Solutions

6.7. Global Aminoglycosides Market, Sub-Segmentation Of Amikacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Formulations

Inhalation Solutions

6.8. Global Aminoglycosides Market, Sub-Segmentation Of Paromomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Formulations

Injectable Formulations

6.9. Global Aminoglycosides Market, Sub-Segmentation Of Streptomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Formulations

Combination Therapies

6.10. Global Aminoglycosides Market, Sub-Segmentation Of Kanamycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Formulations

Oral Formulations

6.11. Global Aminoglycosides Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Combinations Of Aminoglycosides

Novel Aminoglycoside Derivatives

7. Aminoglycosides Market Regional And Country Analysis

7.1. Global Aminoglycosides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Aminoglycosides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aminoglycosides Market

8.1. Asia-Pacific Aminoglycosides Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aminoglycosides Market

9.1. China Aminoglycosides Market Overview

9.2. China Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aminoglycosides Market

10.1. India Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aminoglycosides Market

11.1. Japan Aminoglycosides Market Overview

11.2. Japan Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aminoglycosides Market

12.1. Australia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aminoglycosides Market

13.1. Indonesia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aminoglycosides Market

14.1. South Korea Aminoglycosides Market Overview

14.2. South Korea Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aminoglycosides Market

15.1. Western Europe Aminoglycosides Market Overview

15.2. Western Europe Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aminoglycosides Market

16.1. UK Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aminoglycosides Market

17.1. Germany Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aminoglycosides Market

18.1. France Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aminoglycosides Market

19.1. Italy Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aminoglycosides Market

20.1. Spain Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aminoglycosides Market

21.1. Eastern Europe Aminoglycosides Market Overview

21.2. Eastern Europe Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aminoglycosides Market

22.1. Russia Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aminoglycosides Market

23.1. North America Aminoglycosides Market Overview

23.2. North America Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aminoglycosides Market

24.1. USA Aminoglycosides Market Overview

24.2. USA Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aminoglycosides Market

25.1. Canada Aminoglycosides Market Overview

25.2. Canada Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aminoglycosides Market

26.1. South America Aminoglycosides Market Overview

26.2. South America Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aminoglycosides Market

27.1. Brazil Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aminoglycosides Market

28.1. Middle East Aminoglycosides Market Overview

28.2. Middle East Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aminoglycosides Market

29.1. Africa Aminoglycosides Market Overview

29.2. Africa Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aminoglycosides Market Competitive Landscape And Company Profiles

30.1. Aminoglycosides Market Competitive Landscape

30.2. Aminoglycosides Market Company Profiles

30.2.1. Kremoint Pharma Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Vega Pharma Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Jiangxi Bolai Pharmacy Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Xian Wison Biological Technology Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Hangzhou Uniwise International Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Aminoglycosides Market Other Major And Innovative Companies

31.1. HuvePharma Inc.

31.2. Yi Chang Veterinary Medicine Factory

31.3. Medson Pharmaceuticals

31.4. Medico Remedies Pvt. Ltd.

31.5. Cipla Limited

31.6. Pfizer Inc.

31.7. Allergan PLC

31.8. Teva Pharmaceutical Industries Ltd.

31.9. Zoetis Inc.

31.10. Novartis AG

31.11. Johnson & Johnson Inc.

31.12. Bristol Myers Squibb Company

31.13. Sandoz International GmbH

31.14. Sun Pharmaceutical Industries Ltd.

31.15. Zydus Lifescience limited

32. Global Aminoglycosides Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aminoglycosides Market

34. Recent Developments In The Aminoglycosides Market

35. Aminoglycosides Market High Potential Countries, Segments and Strategies

35.1 Aminoglycosides Market In 2029 - Countries Offering Most New Opportunities

35.2 Aminoglycosides Market In 2029 - Segments Offering Most New Opportunities

35.3 Aminoglycosides Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Aminoglycosides Market, Sub-Segmentation Of Neomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Aminoglycosides Market, Sub-Segmentation Of Tobramycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Aminoglycosides Market, Sub-Segmentation Of Gentamicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Aminoglycosides Market, Sub-Segmentation Of Amikacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Aminoglycosides Market, Sub-Segmentation Of Paromomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Aminoglycosides Market, Sub-Segmentation Of Streptomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Aminoglycosides Market, Sub-Segmentation Of Kanamycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Aminoglycosides Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Aminoglycosides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Global Aminoglycosides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Asia-Pacific, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: China, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: India, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Japan, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Australia, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Indonesia, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: South Korea, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Western Europe, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: UK, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Germany, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: France, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Italy, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Spain, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Eastern Europe, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Russia, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: North America, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: USA, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Canada, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: South America, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Brazil, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Middle East, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Africa, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 82: Kremoint Pharma Pvt. Ltd. Financial Performance
  • Table 83: Vega Pharma Ltd. Financial Performance
  • Table 84: Jiangxi Bolai Pharmacy Co. Ltd. Financial Performance
  • Table 85: Xian Wison Biological Technology Co. Ltd. Financial Performance
  • Table 86: Hangzhou Uniwise International Co. Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Aminoglycosides Market, Sub-Segmentation Of Neomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Aminoglycosides Market, Sub-Segmentation Of Tobramycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Aminoglycosides Market, Sub-Segmentation Of Gentamicin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Aminoglycosides Market, Sub-Segmentation Of Amikacin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Aminoglycosides Market, Sub-Segmentation Of Paromomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Aminoglycosides Market, Sub-Segmentation Of Streptomycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Aminoglycosides Market, Sub-Segmentation Of Kanamycin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Aminoglycosides Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Aminoglycosides Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Global Aminoglycosides Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Asia-Pacific, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: China, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: India, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Japan, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Australia, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Indonesia, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: South Korea, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Western Europe, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: UK, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Germany, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: France, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Italy, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Spain, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Eastern Europe, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Russia, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: North America, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: USA, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Canada, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: South America, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Brazil, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Middle East, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Aminoglycosides Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Aminoglycosides Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Africa, Aminoglycosides Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 82: Kremoint Pharma Pvt. Ltd. Financial Performance
  • Figure 83: Vega Pharma Ltd. Financial Performance
  • Figure 84: Jiangxi Bolai Pharmacy Co. Ltd. Financial Performance
  • Figure 85: Xian Wison Biological Technology Co. Ltd. Financial Performance
  • Figure 86: Hangzhou Uniwise International Co. Ltd. Financial Performance

Frequently Asked Questions

Aminoglycoside is a class of antibiotics that inhibits protein synthesis. These are used in the treatment of aerobic gram-negative bacilli infections of the abdomen and urinary tract, as well as bacteremia and endocarditis For further insights on this market, request a sample here

The market major growth driver - Aminoglycosides Market Surges Amidst Escalating Animal Disease Outbreaks. For further insights on this market, request a sample here

The aminoglycosides market size has grown steadily in recent years. It will grow from $1.84 billion in 2024 to $1.91 billion in 2025 at a compound annual growth rate (CAGR) of 3.9%. The growth in the historic period can be attributed to antibiotic discovery and development, advancements in medicinal chemistry, clinical effectiveness in treating gram-negative infections, broad-spectrum antibacterial activity, hospital-acquired infection control, global population growth, post-surgery infection prevention, research and development investments. The aminoglycosides market size is expected to see strong growth in the next few years. It will grow to " $2.4 billion in 2029 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to advancements in antibiotic stewardship, personalized medicine approaches, innovations in drug delivery, global spread of antibiotic-resistant strains, increasing focus on rare diseases, expanding applications in dermatology, patient education on antibiotic use. Major trends in the forecast period include biotechnological innovations, combination therapies, technological advancements in production, price competition. For further insights on this market, request a sample here

The aminoglycosides market covered in this report is segmented –
1) By Product: Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Other Products
2) By Route Of Administration: Injectables (Parenteral), Feed, Intra-Mammary, Topical, Oral
3) By Application: Veterinary, Skin Infection, Respiratory Diseases, UTI And Pelvic Diseases, Other Diseases Subsegments:
1) By Neomycin: Topical Formulations, Oral Formulations
2) By Tobramycin: Inhalation Solutions, Injectable Formulations, Ophthalmic Solutions
3) By Gentamicin: Injectable Formulations, Topical Formulations, Ophthalmic Solutions
4) By Amikacin: Injectable Formulations, Inhalation Solutions
5) By Paromomycin: Oral Formulations, Injectable Formulations
6) By Streptomycin: Injectable Formulations, Combination Therapies
7) By Kanamycin: Injectable Formulations, Oral Formulations
8) By Other Products: Combinations Of Aminoglycosides, Novel Aminoglycoside Derivatives For further insights on this market,
request a sample here

Asia-Pacific was the largest region in the aminoglycosides market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the aminoglycosides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the aminoglycosides market are Kremoint Pharma Pvt. Ltd., Vega Pharma Ltd., Jiangxi Bolai Pharmacy Co. Ltd., Xian Wison Biological Technology Co. Ltd., Hangzhou Uniwise International Co. Ltd., HuvePharma Inc., Yi Chang Veterinary Medicine Factory, Medson Pharmaceuticals, Medico Remedies Pvt. Ltd., Cipla Limited, Pfizer Inc., Allergan PLC, Teva Pharmaceutical Industries Ltd., Zoetis Inc., Novartis AG, Johnson & Johnson Inc., Bristol Myers Squibb Company, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifescience limited, Lupin Limited, Aurobindo Pharma Limited, Fresenius Kabi AG, Aspen Pharmacare Holdings Limited, Mylan N.V., Sanofi SA, Wyeth Pharmaceuticals Inc., Zhejiang Hisun Pharmaceutical Co. Ltd., GlaxoSmithKline plc . For further insights on this market, request a sample here.

Major trends in this market include Process Innovation Emerges As A Pivotal Trend In The Aminoglycosides Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon